[ad_1]
Written by ANURADHA MASCAREHNAS | Pune |
Posted: November 7, 2018 07:43:01
The vaccine administered as part of the MR campaign is produced in India and approved by the WHO. (Source: File Photo)
The measles-rubella vaccine given to the measles-rubella vaccine will be administered over a six-week period to 3.37 crores of children in the 9-month age group and 15 years, as part of a vaccination program by the Center. The campaign is part of a pledge by India and 10 other member countries of the World Health Organization (WHO) members of the Southeast Asia region, who have resolved to ######################################################################### 39, eliminate measles and fight against conbad rubella / rubella syndrome by 2020. To achieve this goal, the Ministry of Health and Family Welfare of the Union launched the campaign to measles-rubella vaccination (MR) in a progressive manner throughout the country. The campaign aims to cover about 41 crore children.
Neither disease can cure, but the vaccine prevents both. The program will begin in Maharashtra from November 27, told The Indian Express, Archana Patil, the new director of the state's Family Protection Bureau. "The goal is to strengthen immunity against measles and rubella in the community … even children vaccinated against measles by their pediatrician or in health centers should receive the measles-rubella vaccine during the campaign She said.
"This campaign is mbadive and will involve more than one lakh school – badisted by the government, unbadisted and private. Several stakeholders are involved, "added Patil.
In addition to the departments of Health, Women's Welfare and Childhood and Education, organizations such as Lions Clubs, the Indian Academy of Pediatrics and the Indian Medical Association also participate in achieving the greatest coverage during the campaign.
Every year in India, nearly 2.7 million children are infected with measles. Those who survive suffer from serious complications such as diarrhea, pneumonia and malnutrition. Rubella transmission is also widespread in India and can lead to spontaneous abortion, stillbirths at birth and irreversible conbad defects such as permanent disabilities.
Every year, more than 40,000 children are born with conbad anomalies caused by conbad rubella syndrome. 19659006] After finding that sometimes vaccinated children also contracted the disease, health experts administered an extra dose to enhance protection. The vaccine administered as part of the MR campaign is produced in India and approved by WHO.
As with other injectable vaccines, mild pain and redness at the injection site, mild fever, rash and muscle pain, which in turn attenuate themselves. The vaccine is not known to cause other side effects, Patil said.
For the latest news from India, download the application Indian Express
.
[ad_2]
Source link
